|
31999.01.01
|
ABACAVIR+LAMIVUDINE/MYLAN PHARMA F.C.TAB (600+300)MG/TAB BT x 30 (30x1) TABS σε BLISTER (PVC/PVDC/AL)
|
|
104,66 |
120,30 |
147,92 |
Mylan Healthcare Ireland Ltd
|
|
32752.01.03
|
ABEVMY C/S.SOL.IN 25MG/ML 1 VIAL X 16 ML
|
|
570,82 |
634,87 |
720,07 |
Mylan Healthcare Ireland Ltd
|
|
32752.01.01
|
ABEVMY C/S.SOL.IN 25MG/ML 1 VIAL X 4 ML
|
|
147,17 |
169,16 |
204,41 |
Mylan Healthcare Ireland Ltd
|
|
32869.01.06
|
ABIRATERONE MYLAN F.C.TAB 500MG/TAB 60 ΔΙΣΚΙΑ ΣΕ BLISTERS (ALU-PVC/PE/PVDC)
|
|
1.572,26 |
1.748,68 |
1.923,12 |
Mylan Healthcare Ireland Ltd
|
|
25673.02.03
|
ARIXTRA INJ.SOL 1,5MG/0,3ML PF.SYR BTX10 PF.SYR.
|
|
22,34 |
25,67 |
35,37 |
Mylan Healthcare Ireland Ltd
|
|
25673.05.03
|
ARIXTRA INJ.SOL 10MG/0,8ML BTX10PF.SYR
|
|
103,51 |
118,98 |
146,30 |
Mylan Healthcare Ireland Ltd
|
|
25673.01.03
|
ARIXTRA INJ.SOL 2,5MG/0,5ML PF.SYR BTX10PF.SYR.
|
|
29,04 |
33,38 |
45,99 |
Mylan Healthcare Ireland Ltd
|
|
25673.04.03
|
ARIXTRA INJ.SOL 7,5MG/0,6ML BTX10PF.SYR
|
|
94,15 |
108,22 |
133,07 |
Mylan Healthcare Ireland Ltd
|
|
31502.01.06
|
ATORVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx28
|
|
4,63 |
5,32 |
7,34 |
Mylan Healthcare Ireland Ltd
|
|
31502.02.06
|
ATORVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx28
|
|
5,06 |
5,81 |
8,00 |
Mylan Healthcare Ireland Ltd
|
|
31502.03.06
|
ATORVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx28
|
|
5,06 |
5,81 |
8,00 |
Mylan Healthcare Ireland Ltd
|
|
32409.01.01
|
AZACITIDINE MYLAN PD.INJ.SUS 25MG/ML 1 vial x 100 mg
|
|
156,57 |
179,97 |
217,48 |
Mylan Healthcare Ireland Ltd
|
|
31035.02.03
|
CAPECITABINE/MYLAN F.C.TAB 500MG/TAB BTx1 tab x 120 blisters (Al/PVC/PE/PVDC)-unit dose
|
|
71,76 |
82,48 |
104,92 |
Mylan Healthcare Ireland Ltd
|
|
31014.02.03
|
CARVEDILOL/MYLAN F.C.TAB 12,5MG/TAB BTx28 (2 BLIST x14)
|
|
3,00 |
3,45 |
4,75 |
Mylan Healthcare Ireland Ltd
|
|
31014.03.03
|
CARVEDILOL/MYLAN F.C.TAB 25MG/TAB ΒΤx28 (2 BLIST x14)
|
|
3,34 |
3,84 |
5,29 |
Mylan Healthcare Ireland Ltd
|
|
31014.01.03
|
CARVEDILOL/MYLAN F.C.TAB 6,25MG/TAB BTx28 (2 BLIST x14)
|
|
1,42 |
1,64 |
2,26 |
Mylan Healthcare Ireland Ltd
|
|
30601.01.02
|
CHOLIB F.C.TAB (145+20)MG/TAB BTx30 (σε Alu/Alu blister)
|
|
6,83 |
7,85 |
10,82 |
Mylan Healthcare Ireland Ltd
|
|
30601.02.02
|
CHOLIB F.C.TAB (145+40)MG/TAB BTx30 (σε Alu/Alu blister)
|
|
8,30 |
9,55 |
13,17 |
Mylan Healthcare Ireland Ltd
|
|
30866.01.02
|
CLIFT INJ.SO.PFS 20MG/ML BTx28 PF.SYR
|
|
408,89 |
454,77 |
525,44 |
Mylan Healthcare Ireland Ltd
|
|
31059.02.02
|
DONEPEZIL/MYLAN F.C.TAB 10MG/TAB BT x 28 (σε PVDC BLISTER)
|
|
12,89 |
14,81 |
20,41 |
Mylan Healthcare Ireland Ltd
|
|
31059.01.03
|
DONEPEZIL/MYLAN F.C.TAB 5MG/TAB BT x 28 (σε PVDC BLISTER)
|
|
8,99 |
10,33 |
14,24 |
Mylan Healthcare Ireland Ltd
|
|
31368.01.02
|
ESCITALOPRAM/MYLAN F.C.TAB 10MG/TAB BT x 14 TABS σε blisters (PVC/PVdC/Alu)
|
|
2,82 |
3,24 |
4,46 |
Mylan Healthcare Ireland Ltd
|
|
31368.01.05
|
ESCITALOPRAM/MYLAN F.C.TAB 10MG/TAB BT x 30 TABS σε blisters (PVC/PVdC/Alu)
|
|
4,93 |
5,66 |
7,80 |
Mylan Healthcare Ireland Ltd
|
|
31368.02.02
|
ESCITALOPRAM/MYLAN F.C.TAB 20MG/TAB BT x 14 TABS σε blisters (PVC/PVdC/Alu)
|
|
4,96 |
5,71 |
7,87 |
Mylan Healthcare Ireland Ltd
|
|
31368.02.05
|
ESCITALOPRAM/MYLAN F.C.TAB 20MG/TAB BT x 30 TABS σε blisters (PVC/PVdC/Alu)
|
|
9,36 |
10,76 |
14,83 |
Mylan Healthcare Ireland Ltd
|
|
30761.01.06
|
EZETIMIBE+SIMVASTATIN/MYLAN TAB (10+10)MG/TAB BTx(28 x 1) tabs σε blister (unit dose)
|
|
14,33 |
16,47 |
22,70 |
Mylan Healthcare Ireland Ltd
|
|
30761.02.07
|
EZETIMIBE+SIMVASTATIN/MYLAN TAB (10+20)MG/TAB BTx(28 x 1) tabs ( PVC/PVDC-Alu blister-unit dose)
|
|
12,29 |
14,13 |
19,47 |
Mylan Healthcare Ireland Ltd
|
|
30761.03.07
|
EZETIMIBE+SIMVASTATIN/MYLAN TAB (10+40)MG/TAB BTx(28 x 1) tabs ( PVC/PVDC-Alu blister-unit dose)
|
|
12,97 |
14,91 |
20,54 |
Mylan Healthcare Ireland Ltd
|
|
32856.01.18
|
FINGOLIMOD MYLAN CAPS 0.5MG/CAP 28 ΚΑΨΑΚΙΑ - ΣΕ BLISTERS PVC/PE/PVDC/ALU
|
|
744,20 |
827,70 |
930,00 |
Mylan Healthcare Ireland Ltd
|
|
31058.01.07
|
FLUOXETINE/MYLAN CAPS 20MG/CAP BTx28 (BLISTER)
|
|
4,53 |
5,20 |
7,17 |
Mylan Healthcare Ireland Ltd
|
|
19283.01.01
|
FRAXIPARINE INJ.SO.PFS 2850ANTI-XA IU/0,3ML BTx2PF.SYRx0,3ML
|
|
4,67 |
5,37 |
7,40 |
Mylan Healthcare Ireland Ltd
|
|
19283.02.01
|
FRAXIPARINE INJ.SO.PFS 5700ANTI-XA IU/0,6ML ΒΤx2PF.SYR.x0.6ML
|
|
7,76 |
8,91 |
12,27 |
Mylan Healthcare Ireland Ltd
|
|
19283.03.01
|
FRAXIPARINE INJ.SO.PFS 9500ANTI-XA IU/1ML BTX2PF.SYRX1ML
|
|
10,25 |
11,78 |
16,23 |
Mylan Healthcare Ireland Ltd
|
|
31405.01.02
|
GLATIRAMER/MYLAN INJ.SO.PFS 40MG/1ML PF.SYR. BTx12 (PF.SYR x1ML)
|
|
439,25 |
488,54 |
564,46 |
Mylan Healthcare Ireland Ltd
|
|
31192.01.03
|
IMATINIB/MYLAN F.C.TAB 100MG/TAB BTx60 (6x1) σε PVC/PE/PVDC/ALU PERFORATED UNIT-DOSE BLISTERS
|
|
187,41 |
208,44 |
247,46 |
Mylan Healthcare Ireland Ltd
|
|
31192.02.03
|
IMATINIB/MYLAN F.C.TAB 400MG/TAB BTx30 (30x1) σε PVC/PE/PVDC/ALU PERFORATED UNIT-DOSE BLISTERS
|
|
469,81 |
522,52 |
598,18 |
Mylan Healthcare Ireland Ltd
|
|
32640.04.02
|
LENALIDOMIDE MYLAN CAPS 10.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
1.978,71 |
2.200,73 |
2.402,76 |
Mylan Healthcare Ireland Ltd
|
|
32640.05.02
|
LENALIDOMIDE MYLAN CAPS 15.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
2.085,97 |
2.320,03 |
2.526,86 |
Mylan Healthcare Ireland Ltd
|
|
32640.01.03
|
LENALIDOMIDE MYLAN CAPS 2.5MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
1.012,19 |
1.125,77 |
1.252,98 |
Mylan Healthcare Ireland Ltd
|
|
32640.06.03
|
LENALIDOMIDE MYLAN CAPS 20.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
2.640,50 |
2.936,78 |
3.183,03 |
Mylan Healthcare Ireland Ltd
|
|
32640.07.03
|
LENALIDOMIDE MYLAN CAPS 25.0MG/CAP BT x 21 x 1καψάκια - μονάδα δλοσης σε BLISTERS PVC/ACLAR/ αλουμίνιο
|
|
2.443,90 |
2.718,12 |
2.953,23 |
Mylan Healthcare Ireland Ltd
|
|
32640.02.02
|
LENALIDOMIDE MYLAN CAPS 5.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
2.024,37 |
2.251,52 |
2.452,25 |
Mylan Healthcare Ireland Ltd
|
|
32640.03.03
|
LENALIDOMIDE MYLAN CAPS 7.5MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
1.484,03 |
1.650,55 |
1.815,20 |
Mylan Healthcare Ireland Ltd
|
|
31037.03.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (100+25+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,47 |
9,73 |
13,41 |
Mylan Healthcare Ireland Ltd
|
|
31037.04.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (125+31,25+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,02 |
9,22 |
12,71 |
Mylan Healthcare Ireland Ltd
|
|
31037.05.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (150+37,5+200)MG/TAB BTx30 (HDPE Bottle)
|
|
9,31 |
10,70 |
14,74 |
Mylan Healthcare Ireland Ltd
|
|
31037.06.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (200+50+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,61 |
9,89 |
13,63 |
Mylan Healthcare Ireland Ltd
|
|
31037.01.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (50+12.5+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,61 |
9,89 |
13,63 |
Mylan Healthcare Ireland Ltd
|
|
31037.02.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (75+18.75+200)MG/TAB BTx30 (HDPE Bottle)
|
|
9,16 |
10,53 |
14,51 |
Mylan Healthcare Ireland Ltd
|
|
31015.01.05
|
MIRTAZAPINE/MYLAN F.C.TAB 30MG/TAB BTx30 ΣΕ PVDC COATED PVC BLISTER STRIPS WITH ALUMINIUM FOIL LIDDING
|
|
4,94 |
5,68 |
7,82 |
Mylan Healthcare Ireland Ltd
|
|
31015.02.05
|
MIRTAZAPINE/MYLAN F.C.TAB 45MG/TAB BTx30 ΣΕ PVDC COATED PVC BLISTER STRIPS WITH ALUMINIUM FOIL LIDDING
|
|
7,24 |
8,32 |
11,47 |
Mylan Healthcare Ireland Ltd
|
|
31029.02.02
|
MOXONIDINE/MYLAN F.C.TAB 300MCG/TAB BTx 28 (σε BLISTERS)
|
|
3,56 |
4,09 |
5,64 |
Mylan Healthcare Ireland Ltd
|
|
32451.02.01
|
NEPEXTO INJ.SOL 50 MG/1ML 4 PF. SYRS x 1 ML + 4 επιθέματα αλκοόλης
|
|
433,25 |
481,86 |
556,74 |
Mylan Healthcare Ireland Ltd
|
|
32451.02.03
|
NEPEXTO INJ.SOL 50 MG/1ML 4 PF.PEN x 1 ML + 4 επιθέματα αλκοόλης
|
|
433,25 |
481,86 |
556,74 |
Mylan Healthcare Ireland Ltd
|
|
31525.01.02
|
OLMEDIPIN F.C.TAB (20+5)MG/TAB 1 BTx28 TABS σε BLISTER PVC/Alu/OPA-Alu
|
|
6,77 |
7,78 |
10,72 |
Mylan Healthcare Ireland Ltd
|
|
31525.03.02
|
OLMEDIPIN F.C.TAB (40+10)MG/TAB 1 BTx28 TABS σε BLISTER PVC/Alu/OPA-Alu
|
|
7,46 |
8,57 |
11,81 |
Mylan Healthcare Ireland Ltd
|
|
31525.02.02
|
OLMEDIPIN F.C.TAB (40+5)MG/TAB 1 BTx28 TABS σε BLISTER PVC/Alu/OPA-Alu
|
|
6,89 |
7,92 |
10,92 |
Mylan Healthcare Ireland Ltd
|
|
32043.01.01
|
OLMEDIPIN PLUS F.C.TAB (20+5+12.5)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
8,05 |
9,25 |
12,75 |
Mylan Healthcare Ireland Ltd
|
|
32043.04.01
|
OLMEDIPIN PLUS F.C.TAB (40+10+12.5)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
7,94 |
9,13 |
12,58 |
Mylan Healthcare Ireland Ltd
|
|
32043.05.01
|
OLMEDIPIN PLUS F.C.TAB (40+10+25.0)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
8,08 |
9,28 |
12,78 |
Mylan Healthcare Ireland Ltd
|
|
32043.02.01
|
OLMEDIPIN PLUS F.C.TAB (40+5+12.5)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
8,05 |
9,25 |
12,75 |
Mylan Healthcare Ireland Ltd
|
|
32043.03.01
|
OLMEDIPIN PLUS F.C.TAB (40+5+25.0)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
8,18 |
9,40 |
12,95 |
Mylan Healthcare Ireland Ltd
|
|
30576.01.02
|
OLMESARTAN/MYLAN F.C.TAB 10MG/TAB BTx28 (lamιnatedpolyamide/aluminium/polyvinyl chloride/aluminium Blister)
|
|
3,59 |
4,12 |
5,68 |
Mylan Healthcare Ireland Ltd
|
|
30576.02.02
|
OLMESARTAN/MYLAN F.C.TAB 20MG/TAB BTx28 (lamιnatedpolyamide/aluminium/polyvinyl chloride/aluminium Blister)
|
|
4,27 |
4,91 |
6,76 |
Mylan Healthcare Ireland Ltd
|
|
30576.03.02
|
OLMESARTAN/MYLAN F.C.TAB 40MG/TAB BTx28 (lamιnatedpolyamide/aluminium/polyvinyl chloride/aluminium Blister)
|
|
4,05 |
4,66 |
6,42 |
Mylan Healthcare Ireland Ltd
|
|
32143.01.02
|
PEMETREXED/MYLAN C/S.SOL.IN 25MG/ML 1 Vial x20 ml
|
|
415,91 |
462,58 |
534,46 |
Mylan Healthcare Ireland Ltd
|
|
32946.02.04
|
RIVAROXABAN MYLAN TAB 10MG/TAB BT X 10 X 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
9,97 |
11,46 |
15,79 |
Mylan Healthcare Ireland Ltd
|
|
32946.03.08
|
RIVAROXABAN MYLAN TAB 15MG/TAB BT X 28 Χ 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
27,68 |
31,82 |
43,85 |
Mylan Healthcare Ireland Ltd
|
|
32946.01.09
|
RIVAROXABAN MYLAN TAB 2.5MG/TAB BT X 56 Χ 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
28,56 |
32,82 |
45,23 |
Mylan Healthcare Ireland Ltd
|
|
32946.04.07
|
RIVAROXABAN MYLAN TAB 20MG/TAB BT X 28 Χ 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
27,68 |
31,82 |
43,85 |
Mylan Healthcare Ireland Ltd
|
|
31120.02.01
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
3,92 |
4,51 |
6,21 |
Mylan Healthcare Ireland Ltd
|
|
31120.02.16
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
3,92 |
4,51 |
6,21 |
Mylan Healthcare Ireland Ltd
|
|
31120.02.03
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
7,84 |
9,01 |
12,41 |
Mylan Healthcare Ireland Ltd
|
|
31120.02.18
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
7,84 |
9,01 |
12,41 |
Mylan Healthcare Ireland Ltd
|
|
31120.03.01
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
5,52 |
6,35 |
8,76 |
Mylan Healthcare Ireland Ltd
|
|
31120.03.16
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
5,52 |
6,35 |
8,76 |
Mylan Healthcare Ireland Ltd
|
|
31120.03.03
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
11,04 |
12,69 |
17,49 |
Mylan Healthcare Ireland Ltd
|
|
31120.03.18
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
11,04 |
12,69 |
17,49 |
Mylan Healthcare Ireland Ltd
|
|
31120.04.01
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
6,89 |
7,92 |
10,92 |
Mylan Healthcare Ireland Ltd
|
|
31120.04.16
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
6,89 |
7,92 |
10,92 |
Mylan Healthcare Ireland Ltd
|
|
31120.04.03
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
13,71 |
15,76 |
21,72 |
Mylan Healthcare Ireland Ltd
|
|
31120.04.18
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
13,71 |
15,76 |
21,72 |
Mylan Healthcare Ireland Ltd
|
|
31120.01.01
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
1,81 |
2,08 |
2,86 |
Mylan Healthcare Ireland Ltd
|
|
31120.01.16
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
1,81 |
2,08 |
2,86 |
Mylan Healthcare Ireland Ltd
|
|
31120.01.03
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
3,41 |
3,93 |
5,41 |
Mylan Healthcare Ireland Ltd
|
|
31120.01.18
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
3,42 |
3,93 |
5,42 |
Mylan Healthcare Ireland Ltd
|
|
31528.02.03
|
SEIZPAT F.C.TAB 100MG/TAB BTx 56 tabs (σε blister PVC/PVDC-Aluminium)
|
|
34,11 |
39,21 |
54,03 |
Mylan Healthcare Ireland Ltd
|
|
31528.03.03
|
SEIZPAT F.C.TAB 150MG/TAB BTx 56 tabs (σε blister PVC/PVDC-Aluminium)
|
|
51,18 |
58,83 |
74,84 |
Mylan Healthcare Ireland Ltd
|
|
31528.04.03
|
SEIZPAT F.C.TAB 200MG/TAB BTx 56 tabs (σε blister PVC/PVDC-Aluminium)
|
|
68,23 |
78,42 |
99,75 |
Mylan Healthcare Ireland Ltd
|
|
31528.01.01
|
SEIZPAT F.C.TAB 50MG/TAB BTx 14 tabs (σε blister PVC/PVDC-Aluminium)
|
|
4,29 |
4,93 |
6,79 |
Mylan Healthcare Ireland Ltd
|
|
31813.01.01
|
SERKEP INH.SUS.P (25+125)MCG/DOSE BTx1 INHALER x120 metered doses
|
|
14,43 |
16,58 |
22,84 |
Mylan Healthcare Ireland Ltd
|
|
31813.02.01
|
SERKEP INH.SUS.P (25+250)MCG/DOSE BTx1 INHALER x120 metered doses
|
|
19,58 |
22,50 |
31,01 |
Mylan Healthcare Ireland Ltd
|
|
31028.02.05
|
SERTRALINE/MYLAN F.C.TAB 100MG/TAB BTx30 (PVC/PVdC-Alu Blister PACKS)
|
|
5,42 |
6,23 |
8,59 |
Mylan Healthcare Ireland Ltd
|
|
31028.01.05
|
SERTRALINE/MYLAN F.C.TAB 50MG/TAB BTx30 (PVC/PVdC-Alu Blister PACKS)
|
|
4,96 |
5,70 |
7,85 |
Mylan Healthcare Ireland Ltd
|
|
31193.01.04
|
SEVELAMER/MYLAN F.C.TAB 800MG/TAB BTx1 HDPE BOTTLE x 180
|
|
45,27 |
52,04 |
66,20 |
Mylan Healthcare Ireland Ltd
|
|
31042.01.17
|
SIMVASTATIN/MYLAN F.C.TAB 10MG/TAB BT x 30 (σε blisters AL/PVC/PVDC)
|
|
1,15 |
1,32 |
1,82 |
Mylan Healthcare Ireland Ltd
|
|
31042.02.17
|
SIMVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx30(BLISTERS AL/PVC/PVdC)
|
|
4,59 |
5,28 |
7,27 |
Mylan Healthcare Ireland Ltd
|
|
31042.03.17
|
SIMVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx30 (BLISTERS ΑL/PVC/PVdC)
|
|
5,36 |
6,16 |
8,49 |
Mylan Healthcare Ireland Ltd
|
|
32315.03.02
|
SITAGLIPTIN/MYLAN F.C.TAB 100MG/TAB BT X 28 F.C.TABS ΣΕ BLISTER OPA/ALU/PVC//ALU
|
|
12,37 |
14,22 |
19,60 |
Mylan Healthcare Ireland Ltd
|
|
32315.02.02
|
SITAGLIPTIN/MYLAN F.C.TAB 50MG/TAB BT X 28 F.C.TABS ΣΕ BLISTER OPA/ALU/PVC//ALU
|
|
10,10 |
11,61 |
15,99 |
Mylan Healthcare Ireland Ltd
|
|
31026.02.03
|
SOTALOL/MYLAN TAB 160MG/TAB ΒΤx30 (BLISTERS)
|
|
2,85 |
3,27 |
4,51 |
Mylan Healthcare Ireland Ltd
|
|
31026.01.03
|
SOTALOL/MYLAN TAB 80MG/TAB ΒΤx30 (BLISTERS)
|
|
1,91 |
2,19 |
3,03 |
Mylan Healthcare Ireland Ltd
|
|
31016.01.03
|
TAMSULOSIN/MYLAN MOD.R.CA.H 0,4MG/CAP ΒΤ x 20 σε BLISTERS (PVC/PE/PVDC/AL)
|
|
2,52 |
2,90 |
4,00 |
Mylan Healthcare Ireland Ltd
|
|
31646.01.01
|
TIOTROPIUM/MYLAN INHPD.CAP 18MCG/CAP BTx30 caps σε blisters (ALU/ALU/PVC)+ 1 συσκευή NeumoHaler
|
|
13,58 |
15,60 |
21,50 |
Mylan Healthcare Ireland Ltd
|
|
24895.01.01
|
TOBI INH.SOL.N 300MG/5ML BTx 56 AMPSx 5 ML
|
|
1.023,63 |
1.138,48 |
1.267,12 |
Mylan Healthcare Ireland Ltd
|
|
29982.01.02
|
TOBI PODHALER INHPD.CAP 28MG/CAP BTx224 (4x56) καψάκια σε κυψελίδια (alu/alu)+5 συσκευές εισπνοής (μηνιαία πολυσυσκευασία)
|
|
1.735,63 |
1.930,38 |
2.112,71 |
Mylan Healthcare Ireland Ltd
|
|
32252.01.03
|
TUTECVI TAB 50MG/TAB BT X 28 TABS ALU-ALU BLISTER
|
|
8,80 |
10,11 |
13,93 |
Mylan Healthcare Ireland Ltd
|
|
32252.01.04
|
TUTECVI TAB 50MG/TAB BT X 30 TABS ALU-ALU BLISTER
|
|
9,43 |
10,84 |
14,94 |
Mylan Healthcare Ireland Ltd
|
|
32252.01.06
|
TUTECVI TAB 50MG/TAB BT X 60 TABS ALU-ALU BLISTER
|
|
16,59 |
19,07 |
26,28 |
Mylan Healthcare Ireland Ltd
|
|
31023.02.07
|
VENLAFAXINE/MYLAN PR.CAP 150MG/CAP BTx30 (PVC/PE/PVDC/Aluminium foil blister)
|
|
5,00 |
5,75 |
7,93 |
Mylan Healthcare Ireland Ltd
|
